SHAKOPEE, MINNESOTA — GN has announced that its ReSound Sensia hearing aid portfolio is now available to eligible U.S. veterans through Department of Veterans Affairs (VA) audiology clinics and participating care facilities nationwide, expanding access to the company’s latest artificial intelligence-based hearing technology.
Originally introduced in the United States in August 2026, ReSound Sensia incorporates GN’s new AI processing platform, designed to improve speech understanding in challenging listening environments while reducing the need for users to manually adjust hearing aid settings. The technology and its approach to automatic speech-in-noise processing were explored in greater detail in a This Week in Hearing discussion with GN’s Laurel Christensen and Brian Dam Pedersen.
The portfolio includes rechargeable and battery-powered receiver-in-ear hearing aids, custom-made devices, a CROS solution, and bimodal options intended for individuals who use a cochlear implant in one ear and a hearing aid in the other.
“Veterans often have unique hearing needs, and they deserve the latest technology that helps them join in on the moments that matter most to them without worrying about missing the conversations,” said Bob Eastman, Vice President, ReSound Government Services.
“ReSound Sensia provides proven technology that automatically raises the voices that they want to hear, not simply the loudest noise in the room.”
AI Technology Designed to Improve Speech Understanding
At the center of ReSound Sensia is Intelligent All-Around, a sound-processing approach that combines three technologies to support speech understanding across different listening environments.
The system uses AcoustIQ, GN’s environmental classification technology, to analyze surrounding sounds and automatically engage appropriate processing features. According to the company, AcoustIQ demonstrated 88% greater accuracy in environmental classification and feature engagement compared with the closest competing premium solution evaluated in its referenced research.
The platform also incorporates advanced four-microphone directional beamforming and deep neural network (DNN) noise reduction. Together, these technologies are designed to help users focus on the speech source they are facing, rather than automatically prioritizing the loudest voice in the environment.
GN says independent testing conducted at Hörzentrum Oldenburg in Germany demonstrated improvements in the audibility of an intended speaker under challenging listening conditions.
The system automatically responds to changes in the listening environment, reducing the need for users to switch programs or make adjustments through the ReSound Smart 3D app.
Although the technology is designed to operate automatically, actual listening outcomes depend on factors including the acoustic environment, individual hearing needs, and hearing aid configuration.
Expanded Hearing Aid Options for Veterans
The Sensia portfolio provides VA audiologists with several fitting options to accommodate different degrees and configurations of hearing loss.
Available configurations include rechargeable micro receiver-in-ear (microRIE) hearing aids, battery-powered receiver-in-ear models, and custom-made in-the-ear and in-the-canal styles. The broader product family also includes a CROS solution for individuals with unaidable hearing loss in one ear.
The rechargeable microRIE and certain custom styles offer up to 24 hours of battery life, according to specifications released when the platform was introduced in August. Actual runtime varies with usage and operating conditions.
For hearing care professionals, the technology is supported by ReSound Smart Fit 2.4 fitting software, which incorporates the NAL-NL3 prescriptive fitting framework alongside GN’s Audiogram+ approach.
The expanded portfolio gives VA audiologists additional options when considering device style, battery preferences, listening requirements, and fitting characteristics for individual patients.
Bimodal Solutions for Cochlear Implant Users
An important component of the announcement is the inclusion of ReSound Sensia Bimodal and ReSound Enzo IA Bimodal, both designed to work with Cochlear Nucleus sound processors.
These devices are intended for individuals who use a cochlear implant in one ear and an acoustic hearing aid in the opposite ear, a configuration commonly referred to as bimodal hearing.
The products build on GN’s ongoing collaboration with Cochlear through the Smart Hearing Alliance, which focuses on improving the integration of hearing aids and cochlear implant technology.
For eligible veterans with asymmetric hearing needs or an existing cochlear implant, the expanded bimodal offerings provide additional hearing aid options designed for use alongside compatible Cochlear processors.
The announcement also reflects the increasing range of specialized hearing technology available through VA audiology services, extending beyond conventional bilateral hearing aid fittings.
Availability Through VA Hearing Care Programs
ReSound Sensia is now available through VA audiology clinics and participating sites of care across the United States. The announcement follows the product family’s initial commercial introduction in August and extends access to eligible veterans receiving hearing care through the VA system.
The expanded government portfolio includes both conventional hearing aid configurations and specialized CROS and bimodal solutions, giving VA clinicians a broader range of technologies to consider based on individual audiological needs.
For additional information about ReSound hearing technology available through VA and other government hearing care programs, visit the ReSound Government Services website.
Source: GN / ReSound
